Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Licha Bio is a synthetic biology company based in Shanghai that specializes in the bio-manufacturing of high-value natural products. Founded by Dr. Li Cha, the company utilizes a proprietary metabolic engineering platform to produce complex molecules such as ergothioneine, ginsenosides, and squalene through microbial fermentation. These products serve as key ingredients for the healthcare, cosmetics, and nutrition industries, offering a sustainable and high-purity alternative to traditional chemical synthesis or plant extraction. Licha Bio integrates computational biology with high-throughput screening to optimize microbial strains for industrial-scale production. The company has secured significant venture capital funding to expand its manufacturing capabilities and global market reach.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Li Cha.